IBDEI0DP ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34368,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
 ;;^UTILITY(U,$J,358.3,34368,1,4,0)
 ;;=4^C91.11
 ;;^UTILITY(U,$J,358.3,34368,2)
 ;;=^5001766
 ;;^UTILITY(U,$J,358.3,34369,0)
 ;;=C91.10^^105^1433^53
 ;;^UTILITY(U,$J,358.3,34369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34369,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
 ;;^UTILITY(U,$J,358.3,34369,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,34369,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,34370,0)
 ;;=C92.11^^105^1433^54
 ;;^UTILITY(U,$J,358.3,34370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34370,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
 ;;^UTILITY(U,$J,358.3,34370,1,4,0)
 ;;=4^C92.11
 ;;^UTILITY(U,$J,358.3,34370,2)
 ;;=^5001793
 ;;^UTILITY(U,$J,358.3,34371,0)
 ;;=C92.10^^105^1433^55
 ;;^UTILITY(U,$J,358.3,34371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34371,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
 ;;^UTILITY(U,$J,358.3,34371,1,4,0)
 ;;=4^C92.10
 ;;^UTILITY(U,$J,358.3,34371,2)
 ;;=^5001792
 ;;^UTILITY(U,$J,358.3,34372,0)
 ;;=D47.1^^105^1433^56
 ;;^UTILITY(U,$J,358.3,34372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34372,1,3,0)
 ;;=3^Chronic Myeloproliferative Disease
 ;;^UTILITY(U,$J,358.3,34372,1,4,0)
 ;;=4^D47.1
 ;;^UTILITY(U,$J,358.3,34372,2)
 ;;=^5002256
 ;;^UTILITY(U,$J,358.3,34373,0)
 ;;=C82.69^^105^1433^57
 ;;^UTILITY(U,$J,358.3,34373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34373,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34373,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,34373,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,34374,0)
 ;;=C82.60^^105^1433^58
 ;;^UTILITY(U,$J,358.3,34374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34374,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34374,1,4,0)
 ;;=4^C82.60
 ;;^UTILITY(U,$J,358.3,34374,2)
 ;;=^5001521
 ;;^UTILITY(U,$J,358.3,34375,0)
 ;;=D56.2^^105^1433^59
 ;;^UTILITY(U,$J,358.3,34375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34375,1,3,0)
 ;;=3^Delta-Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,34375,1,4,0)
 ;;=4^D56.2
 ;;^UTILITY(U,$J,358.3,34375,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,34376,0)
 ;;=D75.9^^105^1433^60
 ;;^UTILITY(U,$J,358.3,34376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34376,1,3,0)
 ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
 ;;^UTILITY(U,$J,358.3,34376,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,34376,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,34377,0)
 ;;=D59.0^^105^1433^63
 ;;^UTILITY(U,$J,358.3,34377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34377,1,3,0)
 ;;=3^Drug-Induced Autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,34377,1,4,0)
 ;;=4^D59.0
 ;;^UTILITY(U,$J,358.3,34377,2)
 ;;=^5002323
 ;;^UTILITY(U,$J,358.3,34378,0)
 ;;=D59.2^^105^1433^64
 ;;^UTILITY(U,$J,358.3,34378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34378,1,3,0)
 ;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,34378,1,4,0)
 ;;=4^D59.2
 ;;^UTILITY(U,$J,358.3,34378,2)
 ;;=^5002325
 ;;^UTILITY(U,$J,358.3,34379,0)
 ;;=R59.9^^105^1433^67
 ;;^UTILITY(U,$J,358.3,34379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34379,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,34379,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,34379,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,34380,0)
 ;;=D47.3^^105^1433^68
 ;;^UTILITY(U,$J,358.3,34380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34380,1,3,0)
 ;;=3^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,34380,1,4,0)
 ;;=4^D47.3
 ;;^UTILITY(U,$J,358.3,34380,2)
 ;;=^5002258
 ;;^UTILITY(U,$J,358.3,34381,0)
 ;;=C82.09^^105^1433^69
 ;;^UTILITY(U,$J,358.3,34381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34381,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34381,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,34381,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,34382,0)
 ;;=C82.00^^105^1433^70
 ;;^UTILITY(U,$J,358.3,34382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34382,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,34382,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,34382,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,34383,0)
 ;;=C82.19^^105^1433^71
 ;;^UTILITY(U,$J,358.3,34383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34383,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34383,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,34383,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,34384,0)
 ;;=C82.10^^105^1433^72
 ;;^UTILITY(U,$J,358.3,34384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34384,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,34384,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,34384,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,34385,0)
 ;;=C82.29^^105^1433^73
 ;;^UTILITY(U,$J,358.3,34385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34385,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34385,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,34385,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,34386,0)
 ;;=C82.20^^105^1433^74
 ;;^UTILITY(U,$J,358.3,34386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34386,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Unspec Site
 ;;^UTILITY(U,$J,358.3,34386,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,34386,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,34387,0)
 ;;=C82.39^^105^1433^75
 ;;^UTILITY(U,$J,358.3,34387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34387,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34387,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,34387,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,34388,0)
 ;;=C82.30^^105^1433^76
 ;;^UTILITY(U,$J,358.3,34388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34388,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,34388,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,34388,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,34389,0)
 ;;=C82.49^^105^1433^77
 ;;^UTILITY(U,$J,358.3,34389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34389,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34389,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,34389,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,34390,0)
 ;;=C82.40^^105^1433^78
 ;;^UTILITY(U,$J,358.3,34390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34390,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,34390,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,34390,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,34391,0)
 ;;=C82.99^^105^1433^79
 ;;^UTILITY(U,$J,358.3,34391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34391,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34391,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,34391,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,34392,0)
 ;;=C82.90^^105^1433^80
 ;;^UTILITY(U,$J,358.3,34392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34392,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,34392,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,34392,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,34393,0)
 ;;=R59.1^^105^1433^65
 ;;^UTILITY(U,$J,358.3,34393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34393,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,34393,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,34393,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,34394,0)
 ;;=C91.40^^105^1433^84
 ;;^UTILITY(U,$J,358.3,34394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34394,1,3,0)
 ;;=3^Hairy Cell Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34394,1,4,0)
 ;;=4^C91.40
 ;;^UTILITY(U,$J,358.3,34394,2)
 ;;=^5001771
 ;;^UTILITY(U,$J,358.3,34395,0)
 ;;=C91.42^^105^1433^82
 ;;^UTILITY(U,$J,358.3,34395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34395,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34395,1,4,0)
 ;;=4^C91.42
 ;;^UTILITY(U,$J,358.3,34395,2)
 ;;=^5001773
 ;;^UTILITY(U,$J,358.3,34396,0)
 ;;=C91.41^^105^1433^83
 ;;^UTILITY(U,$J,358.3,34396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34396,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34396,1,4,0)
 ;;=4^C91.41
 ;;^UTILITY(U,$J,358.3,34396,2)
 ;;=^5001772
 ;;^UTILITY(U,$J,358.3,34397,0)
 ;;=D57.01^^105^1433^85
 ;;^UTILITY(U,$J,358.3,34397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34397,1,3,0)
 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,34397,1,4,0)
 ;;=4^D57.01
 ;;^UTILITY(U,$J,358.3,34397,2)
 ;;=^5002307
 ;;^UTILITY(U,$J,358.3,34398,0)
 ;;=D57.00^^105^1433^86
 ;;^UTILITY(U,$J,358.3,34398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34398,1,3,0)
 ;;=3^Hb-SS Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,34398,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,34398,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,34399,0)
 ;;=D57.02^^105^1433^87
 ;;^UTILITY(U,$J,358.3,34399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34399,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,34399,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,34399,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,34400,0)
 ;;=D68.32^^105^1433^89
 ;;^UTILITY(U,$J,358.3,34400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34400,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,34400,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,34400,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,34401,0)
 ;;=C22.2^^105^1433^90
 ;;^UTILITY(U,$J,358.3,34401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34401,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,34401,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,34401,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,34402,0)
 ;;=D58.9^^105^1433^92
 ;;^UTILITY(U,$J,358.3,34402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34402,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34402,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,34402,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,34403,0)
 ;;=C81.99^^105^1433^93
 ;;^UTILITY(U,$J,358.3,34403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34403,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34403,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,34403,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,34404,0)
 ;;=C81.90^^105^1433^94
 ;;^UTILITY(U,$J,358.3,34404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34404,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34404,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,34404,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,34405,0)
 ;;=D89.2^^105^1433^95
 ;;^UTILITY(U,$J,358.3,34405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34405,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,34405,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,34405,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,34406,0)
 ;;=D05.12^^105^1433^98
 ;;^UTILITY(U,$J,358.3,34406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34406,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,34406,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,34406,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,34407,0)
 ;;=D05.11^^105^1433^99
 ;;^UTILITY(U,$J,358.3,34407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34407,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,34407,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,34407,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,34408,0)
 ;;=D05.10^^105^1433^100
 ;;^UTILITY(U,$J,358.3,34408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34408,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,34408,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,34408,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,34409,0)
 ;;=D50.0^^105^1433^101
 ;;^UTILITY(U,$J,358.3,34409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34409,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,34409,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,34409,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,34410,0)
 ;;=D50.9^^105^1433^102
 ;;^UTILITY(U,$J,358.3,34410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34410,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34410,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,34410,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,34411,0)
 ;;=C46.9^^105^1433^103
 ;;^UTILITY(U,$J,358.3,34411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34411,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,34411,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,34411,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,34412,0)
 ;;=C22.0^^105^1433^104
 ;;^UTILITY(U,$J,358.3,34412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34412,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,34412,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,34412,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,34413,0)
 ;;=D05.02^^105^1433^105
 ;;^UTILITY(U,$J,358.3,34413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34413,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,34413,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,34413,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,34414,0)
 ;;=D05.01^^105^1433^106
 ;;^UTILITY(U,$J,358.3,34414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34414,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,34414,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,34414,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,34415,0)
 ;;=D05.00^^105^1433^107
 ;;^UTILITY(U,$J,358.3,34415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34415,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,34415,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,34415,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,34416,0)
 ;;=R59.0^^105^1433^66
 ;;^UTILITY(U,$J,358.3,34416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34416,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,34416,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,34416,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,34417,0)
 ;;=C83.59^^105^1433^108
 ;;^UTILITY(U,$J,358.3,34417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34417,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34417,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,34417,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,34418,0)
 ;;=C83.50^^105^1433^109
 ;;^UTILITY(U,$J,358.3,34418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34418,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34418,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,34418,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,34419,0)
 ;;=C43.9^^105^1433^112
 ;;^UTILITY(U,$J,358.3,34419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34419,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,34419,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,34419,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,34420,0)
 ;;=C31.9^^105^1433^113
 ;;^UTILITY(U,$J,358.3,34420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34420,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,34420,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,34420,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,34421,0)
 ;;=C24.1^^105^1433^115
 ;;^UTILITY(U,$J,358.3,34421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34421,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,34421,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,34421,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,34422,0)
 ;;=C21.0^^105^1433^116
 ;;^UTILITY(U,$J,358.3,34422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34422,1,3,0)
 ;;=3^Malig Neop Anus,Unspec
 ;;^UTILITY(U,$J,358.3,34422,1,4,0)
 ;;=4^C21.0
 ;;^UTILITY(U,$J,358.3,34422,2)
 ;;=^5000930
 ;;^UTILITY(U,$J,358.3,34423,0)
 ;;=C67.9^^105^1433^119
 ;;^UTILITY(U,$J,358.3,34423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34423,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,34423,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,34423,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,34424,0)
 ;;=C71.9^^105^1433^123
 ;;^UTILITY(U,$J,358.3,34424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34424,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,34424,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,34424,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,34425,0)
 ;;=C18.9^^105^1433^125
 ;;^UTILITY(U,$J,358.3,34425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34425,1,3,0)
 ;;=3^Malig Neop Colon,Unspec
 ;;^UTILITY(U,$J,358.3,34425,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,34425,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,34426,0)
 ;;=C49.9^^105^1433^126
 ;;^UTILITY(U,$J,358.3,34426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34426,1,3,0)
 ;;=3^Malig Neop Connective/Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,34426,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,34426,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,34427,0)
 ;;=C62.12^^105^1433^127
 ;;^UTILITY(U,$J,358.3,34427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34427,1,3,0)
 ;;=3^Malig Neop Descended Left Testis
 ;;^UTILITY(U,$J,358.3,34427,1,4,0)
 ;;=4^C62.12
 ;;^UTILITY(U,$J,358.3,34427,2)
 ;;=^5001235
 ;;^UTILITY(U,$J,358.3,34428,0)
 ;;=C62.11^^105^1433^128
 ;;^UTILITY(U,$J,358.3,34428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34428,1,3,0)
 ;;=3^Malig Neop Descended Right Testis
 ;;^UTILITY(U,$J,358.3,34428,1,4,0)
 ;;=4^C62.11
 ;;^UTILITY(U,$J,358.3,34428,2)
 ;;=^5001234
 ;;^UTILITY(U,$J,358.3,34429,0)
 ;;=C15.9^^105^1433^129
 ;;^UTILITY(U,$J,358.3,34429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34429,1,3,0)
 ;;=3^Malig Neop Esophagus,Unspec
 ;;^UTILITY(U,$J,358.3,34429,1,4,0)
 ;;=4^C15.9
 ;;^UTILITY(U,$J,358.3,34429,2)
 ;;=^5000919
 ;;^UTILITY(U,$J,358.3,34430,0)
 ;;=C24.0^^105^1433^130
 ;;^UTILITY(U,$J,358.3,34430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34430,1,3,0)
 ;;=3^Malig Neop Extrahepatic Bile Duct
 ;;^UTILITY(U,$J,358.3,34430,1,4,0)
 ;;=4^C24.0
 ;;^UTILITY(U,$J,358.3,34430,2)
 ;;=^5000940
 ;;^UTILITY(U,$J,358.3,34431,0)
 ;;=C23.^^105^1433^132
 ;;^UTILITY(U,$J,358.3,34431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34431,1,3,0)
 ;;=3^Malig Neop Gallbladder
 ;;^UTILITY(U,$J,358.3,34431,1,4,0)
 ;;=4^C23.
 ;;^UTILITY(U,$J,358.3,34431,2)
 ;;=^267098
 ;;^UTILITY(U,$J,358.3,34432,0)
 ;;=C32.9^^105^1433^136
 ;;^UTILITY(U,$J,358.3,34432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34432,1,3,0)
 ;;=3^Malig Neop Larynx,Unspec
 ;;^UTILITY(U,$J,358.3,34432,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,34432,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,34433,0)
 ;;=C64.2^^105^1433^140
 ;;^UTILITY(U,$J,358.3,34433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34433,1,3,0)
 ;;=3^Malig Neop Left Kidney,Except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,34433,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,34433,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,34434,0)
 ;;=C65.2^^105^1433^143
 ;;^UTILITY(U,$J,358.3,34434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34434,1,3,0)
 ;;=3^Malig Neop Left Renal Pelvis
 ;;^UTILITY(U,$J,358.3,34434,1,4,0)
 ;;=4^C65.2
 ;;^UTILITY(U,$J,358.3,34434,2)
 ;;=^5001252
 ;;^UTILITY(U,$J,358.3,34435,0)
 ;;=C62.92^^105^1433^144
